Status:
COMPLETED
Comparison of Humeral or Thoracic Implantation of an Central Veinous Access by an Implantable Venous Access Device in Patients With Solid Tumors Requiring Chemotherapy
Lead Sponsor:
Center Eugene Marquis
Conditions:
Solid Tumor, Adult
Chemotherapy Treatment
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to compare the humeral and thoracic implantation of a central venous access by an implantable device in patients with solids tumors who require intravenous chemotherapy. This ...
Eligibility Criteria
Inclusion
- Patients with solid tumors at an Advanced or metastasis stage requiring placement of implantable catheter for intravenous chemotherapy treatment
- Older than 18 years
- Express signed consent
Exclusion
- Life expectancy less than 12 months assessed by investigator
- Infection or uncontrolled suspected infection
- Medical contraindication to port implantation by catheter in thoracic or humeral location
- Pregnant or lactating women
- Abnormal coagulation
- Immunosuppressed patients (for example known hepatitis B or C, or known positive Human Immunodeficiency Virus due to the spreading risk)
- Patient not affiliated to the French social security
- Access time to the humeral or thoracic port placement higher than 15 days (from the randomization theoretical date)
- Protected Adult or adult deprived of liberty
Key Trial Info
Start Date :
March 9 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 17 2024
Estimated Enrollment :
361 Patients enrolled
Trial Details
Trial ID
NCT03410121
Start Date
March 9 2018
End Date
September 17 2024
Last Update
August 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center Eugene Marquis
Rennes, Brittany Region, France, 35000